1-3 of 3
Raz Somech, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Novel Immune Checkpoint Deficiency and Susceptibility to EBV-Associated Lymphoma

Ido Somekh, Thomas Magg, PhD, Alejandro Gallón Duque, Tali Stauber, MD, Atar Lev, MSc, Ekrem Unal, MD, Amos J. Simon, PhD, Meino Rohlfs, PhD, Raffaele Conca, MSc, Megumi Tatematsu, PhD, Fabian Hauck, MD PhD, Raz Somech, MD PhD, Christoph Klein, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2326.
https://doi.org/10.1182/blood-2019-128296
Published: 2019
Journal Articles

Novel Mutations in RASGRP1 Are Associated with Immune Dysregulation and Predispose to EBV-Induced Lymphoma

Ido Somekh, MD, Benjamin Marquardt, MSc, Yanshan Liu, PhD, Meino Rohlfs, PhD, Shirly Frizinsky, MD, Ekrem Unal, MD, Daniel Kotlarz, MD PhD, Raz Somech, MD PhD, Christoph Klein, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2287.
https://doi.org/10.1182/blood.V130.Suppl_1.2287.2287
Published: 2017
Journal Articles

Maintenance Therapy with Nilotinib (Tasigna) Post Allogeneic Stem Cell Transplantation (AlloSCT) for Advanced (>CP 1 ) Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL)

Arnon Nagler, MD, Yulia Volchek, MD, Nira Bloom, Ph.D, Raz Somech, MD, Ronit Yerushalmi, MD, Avichai Shimoni, MD
Journal: Blood
Blood (2011) 118 (21): 2011.
https://doi.org/10.1182/blood.V118.21.2011.2011
Published: 2011